← Back to Search

The Low Back Pain and Disability Drivers Management model for Lower Back Pain

N/A
Waitlist Available
Led By Yannick Tousignant-Laflamme, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
be working with patients presenting with LBP
be able to participate in a one-day training workshop
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t2 (12 weeks post enrollment for patients and through study completion, up to nine months for clinicians)
Awards & highlights

Study Summary

This study is evaluating whether a set of activities can improve pain and disability in people with low back pain.

Eligible Conditions
  • Lower Back Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to nine months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to nine months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinicians' compliance to study protocol/fidelity of intervention
Number of participants recruited for the study
Retention rate of participants
+1 more
Secondary outcome measures
Change from baseline in cognitive-affective drivers of pain and disability at 12 weeks
Change from baseline in contextual drivers of pain and disability at 12 weeks
Change from baseline in nervous system dysfunctions at 12 weeks
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: The Low Back Pain and Disability Drivers Management modelExperimental Treatment1 Intervention
Participating clinicians in the intervention arm will use the PDDM model to guide assessment and treatment of their patients and data will be collected over a 12-weeks period.
Group II: Low back pain clinical practice guidelinesActive Control1 Intervention
Participating clinicians in the active comparator arm will perform assessment and treatment of their patients based on the recommendations from the most recent and high-quality clinical practice guidelines (CPGs) and data will be collected over a 12-weeks period.

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
290 Previous Clinical Trials
68,861 Total Patients Enrolled
Yannick Tousignant-Laflamme, PhDPrincipal InvestigatorUniversité de Sherbrooke
2 Previous Clinical Trials
108 Total Patients Enrolled
Michel Tousignant, PhDPrincipal InvestigatorUniversité de Sherbrooke
2 Previous Clinical Trials
144 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~22 spots leftby Mar 2025